Cineverse reaffirms fiscal 2027 guidance of $115M-$120M revenue and $10M-$20M adjusted EBITDA following IndiCue and Giant acquisitions (NASDAQ:CNVS)
Cineverse (CNVS) Q4 FY2026 earnings call: acquisition impact, AI ad-tech pivot, FY2027 guidance, margins, liquidity and risks.
YayaNews contributes financial news and market context through the YayaNews editorial workflow.

Cineverse (CNVS) Q4 FY2026 earnings call: acquisition impact, AI ad-tech pivot, FY2027 guidance, margins, liquidity and risks.
Cineverse reaffirms fiscal 2027 guidance of $115M-$120M revenue and $10M-$20M adjusted EBITDA following IndiCue and Giant acquisitions (NASDAQ:CNVS) | Seeking Alpha
Copy Link
Save
Play
(
10min
)
Comments
Earnings Call Insights: Cineverse Corp. (CNVS) Q4 fiscal 2026
Management View
Chris McGurk said the quarter reflected both the base business and the initial impact of the two acquisitions, stating, "We generated $26 million in consolidated revenues, up 67% over the prior year period," and adding
Seeking Alpha's Disclaimer:
This article was automatically generated by an AI tool based on content available on the Seeking Alpha website, and has not been curated or reviewed by humans. Due to inherent limitations in using AI-based tools, the accuracy, completeness, or timeliness of such articles cannot be guaranteed. This article is intended for informational purposes only. Seeking Alpha does not take account of your objectives or your financial situation and does not offer any personalized investment advice. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank.
To ensure this doesnât happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please
report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.
Search field
Entering text into the input field will update the search result below
Entering text into the input field will update the search result below
Quick Insights
How will Cineverse's recent acquisitions impact revenue and EBITDA guidance?
Cineverse expects acquisitions of Giant Worldwide and IndiCue to be major growth engines, reaffirming guidance for $115-120 million in revenue and $10-20 million in adjusted EBITDA, with over 50% of revenue to be technology-based.
What are the main risks to Cineverseâs profitability outlook after acquisitions?
Profitability depends on successful integration and cost savings from acquisitions, with current risks from advertising market pressures, competitive FAST supply, and a negative working capital position reliant on an expanded ATM facility.
How are market and industry dynamics affecting Cineverseâs monetization and margins?
CPMs and fill rates face pressure from heavy FAST/channel inventory, impacting monetization; management expects margin improvement as integration progresses, aided by the differentiated Matchpoint stack and increased political advertising seasonality.
Recommended For You
More
Trending News
See More
»
Original YayaNews editorial coverage, published for informational purposes.
This article is sourced from Seeking Alpha. It is for informational purposes only and does not constitute investment advice.
Topics & Symbols
Continue Reading
Related Reading
Organigram surges 10% on record Q3 results (OGI:NASDAQ)
Organigram Global (OGI) shares jump after record Q3 revenue & EBITDA, boosted by Sanity Group acquisition and margin gains.

Anthropic models released in EU now embed watermarks on all AI-generated content
Anthropicâs Claude models in the EU will embed watermarks and provenance metadata under the EU AI Act Article 50âsee what changes Aug. 2, 2026.

Altius Minerals Raises Quarterly Dividend 10% to C$0.11, Extending Growth Streak and Signaling Cash Flow Confidence
Altius Minerals increases its quarterly dividend by 10% to C$0.11 per share, continuing its multi-year growth record. This article analyzes its business model, financial health, and industry trends, exploring shareholder return strategies and potential risks for royalty companies.

BIO-key International enters $2.5M warrant inducement transaction (BKYI:NASDAQ)
BIO-key International (BKYI) enters warrant inducement deal to raise ~$2.5M gross proceeds, issuing new warrants pending Nasdaq approval.
